Related Experiment Videos
The dilemma of isolated systolic hypertension
Insights
Isolated systolic hypertension is a key cardiovascular disease risk factor. Treatment with thiazide diuretics and potentially methyldopa is beneficial for patients under 80 with severe systolic elevation or organ damage.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Isolated systolic hypertension (ISH) is defined by high systolic blood pressure (≥150–165 mm Hg) with normal diastolic pressure (<90–95 mm Hg).
- ISH, often associated with atherosclerosis, is a significant risk factor for cardiovascular disease.
- Atherosclerosis is a condition where plaque builds up inside arteries.
Purpose of the Study:
- To review the significance of isolated systolic hypertension as a cardiovascular disease risk factor.
- To outline therapeutic interventions for ISH in patients under 80 years old.
- To discuss the efficacy and safety of pharmacological treatments for ISH.
Main Methods:
- Literature review of studies on isolated systolic hypertension and its management.
- Analysis of treatment guidelines for hypertension in elderly populations.
- Evaluation of the effectiveness of thiazide diuretics and methyldopa in ISH patients.
Main Results:
- ISH is a recognized risk factor for cardiovascular disease.
- Therapeutic intervention is recommended for patients under 80 with systolic pressure ≥200 mm Hg, or ≥180 mm Hg with target organ damage.
- Low-dose thiazide diuretics are safe and effective for lowering systolic pressure.
Conclusions:
- Isolated systolic hypertension requires careful management due to its cardiovascular risks.
- Thiazide diuretics are a primary treatment option for ISH.
- Methyldopa can be added if blood pressure remains elevated after initial treatment.
Abstract:
Isolated systolic hypertension, characterized by elevated systolic blood pressure (greater than 150 to 165 mm Hg), normal diastolic blood pressure (less than 90 to 95 mm Hg) and, often, atherosclerosis, is now recognized as an important risk factor for cardiovascular disease. When the systolic pressure is 200 mm Hg or greater, or when it is 180 mm Hg or greater and accompanied by target organ damage, therapeutic intervention may be of value in patients under the age of 80 years. Low doses of thiazide diuretics have been shown to be safe and effective in lowering the systolic pressure. If the blood pressure remains high, treatment with methyldopa may be added.